Developing models to understand infectious diseases.
Official title: Pre-Clinical Models of Infectious Diseases
Funded at Iit Research Institute · NIH-11197666 · Data updated 2026-11-12
This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iit Research Institute NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00012-0-759302400001-1 |
| Project ID | NIH-11197666 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would include individuals at risk of infectious diseases or those who have been diagnosed with such conditions.
✕Less likely to help
Patients with non-infectious diseases or those who are not at risk for infectious diseases may not receive any benefit from this research.
What this research studies
This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and effects. By using these models, researchers aim to test potential medical countermeasures and treatments before they are used in humans. Patients may benefit from the insights gained through this research, which could lead to improved therapies for infectious diseases. The approach involves rigorous testing and evaluation of various reagents and developmental strategies to ensure effectiveness and safety.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments and preventive measures for infectious diseases.
How similar studies have gone: Other research has shown success in developing pre-clinical models for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
-
Iit Research Institute
Chicago, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Exploring safe dosage levels for new therapeutic compounds.
This study is looking for safe dosage levels for new treatments aimed at helping people with neurological conditions, and if you join, you could help test these promising therapies to see how well they work and if they're safe for patients like you.
-
Developing models to understand infectious diseases.
This study is working on creating models that mimic infectious diseases to help researchers find better treatments, so patients can have more effective options in the future.
-
Investigating the safety of AIT-102 in rats and dogs
This study is looking at how a drug called AIT-102 affects the health of rats and dogs to find out if it can harm specific organs and if those effects can be fixed, which will help make sure it's safe for people in the future.
-
Understanding the safety of new cancer drugs before they are tested in people
This study is looking at the safety of new small molecule drugs that could help treat cancer and other conditions, and it brings together experts to make sure these drugs are safe before they are tested on people, which could lead to better treatments for patients like you.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.